Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real‐world analysis from the Chinese Myeloma Committee
Xuelin Dou(Peking University), Jin Lu(Peking University), Chunrui Li(Tongji Hospital), Jia Song(Tianjin Chengjian University), Aijun Liao(China Medical University), Juan Du(Shanghai Jiao Tong University), Yuping Zhong(Qingdao University), Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Jinlei Qi(National Center for Chronic and Noncommunicable Disease Control and Prevention), Sinan Gu(Shanghai Changzheng Hospital), Liru Wang(Cotton Research Institute), Juan Li(Sun Yat-sen University), Rong Fu(Tianjin Medical University General Hospital), Ling Qin(First Affiliated Hospital of Henan University of Science and Technology), Jun Luo(Guangxi Medical University), Lei Wen(Peking University), Nan Peng(Peking University), Lifen Kuang(Sun Yat-sen University), Yang Liu(Peking University), Zhongqing Li(Guangxi Medical University)
Cited by 0
Related Papers
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k